CYP1A2 and ovarian cancer: Interestingly, Terry et al.(2007) and Merritt et al.(2013) reported a potential association between ovarian cancer risk and geneticvariations influencing caffeine metabolism, particularly within the CYP1A1 and CYP1A2 genesencoding cytochrome P450 enzymes responsible for caffeine breakdown.